PD-L1 in non-small-cell lung cancer: the third target for immunotherapy

Egbert F. Smit, Michel M. van den Heuvel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1795-1796
JournalLancet
Volume387
Issue number10030
DOIs
Publication statusPublished - 30 Apr 2016

Cite this

Smit, Egbert F. ; van den Heuvel, Michel M. / PD-L1 in non-small-cell lung cancer: the third target for immunotherapy. In: Lancet. 2016 ; Vol. 387, No. 10030. pp. 1795-1796.
@article{8ca4de521aa54e4b97eefaf763fef960,
title = "PD-L1 in non-small-cell lung cancer: the third target for immunotherapy",
author = "Smit, {Egbert F.} and {van den Heuvel}, {Michel M.}",
year = "2016",
month = "4",
day = "30",
doi = "10.1016/S0140-6736(16)00700-5",
language = "English",
volume = "387",
pages = "1795--1796",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10030",

}

PD-L1 in non-small-cell lung cancer: the third target for immunotherapy. / Smit, Egbert F.; van den Heuvel, Michel M.

In: Lancet, Vol. 387, No. 10030, 30.04.2016, p. 1795-1796.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - PD-L1 in non-small-cell lung cancer: the third target for immunotherapy

AU - Smit, Egbert F.

AU - van den Heuvel, Michel M.

PY - 2016/4/30

Y1 - 2016/4/30

U2 - 10.1016/S0140-6736(16)00700-5

DO - 10.1016/S0140-6736(16)00700-5

M3 - Article

VL - 387

SP - 1795

EP - 1796

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 10030

ER -